Apoteket's operating cash flow stood at SEK 51.8 mil in 4Q2004, down 65.2% when compared to the previous year. Historically, between 1Q2001 - 4Q2004, the firm’s operating cash flow reached a high of SEK 149 mil in 4Q2003 and a low of SEK -142 mil in 3Q2001.
Apoteket's total investments stood at SEK -43.2 mil and accounted for 0.505% of sales in 4Q2004. This is compared to an average of 0.052% as seen over the last five years.
Cash from financing amounted to SEK -11.6 mil, so the company generated SEK -3.02 mil net cash in 4Q2004.
At the end of 4Q2004, the company had a net debt of SEK 1,526 mil, or 2.96x of EBITDA and 60.9% of equity. Net working capital amounted to SEK 2,448 mil, or 28.6% of sales. Cash conversion cycle is negative and reached days in 4Q2004. This means Apoteket generates revenue from customers before it has to pay its suppliers for inventory, among other things.
You can see all the company’s data at Apoteket profile, or you can download a report on the company in the report section.
Helgi Library 
